Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Translational Cancer Research|February 4, 2022
Establishment and application of a method of next generation sequencing of 285 genes in lung cancer based on Ion-Proton platformYu Chen, Xu-Chao Zhang, Wen-Qing Yan, et al.
Angewandte Chemie (International Ed. in English)|April 29, 2026
Decoupling Hydrogen Evolution From Continuous Irradiation via CO2-Mediated Proton-Coupled Electron StorageHua-Qing Yin, Zhi-Yi Lv, Min-Min Guo, et al.
JTO Clinical and Research Reports|December 17, 2021
Response to Icotinib Plus Chemotherapy in Pulmonary Atypical Carcinoid Harboring the EGFR L858R Mutation: A Brief ReportYu-Qing Chen, Yu-Fa Li, Chan-Yuan Zhang, et al.
Thoracic Cancer|December 4, 2019
Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinomaKai Yin, Hui-Bo Feng, Lin-Lin Li, et al.
Cancer Treatment and Research Communications|January 30, 2023
The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patientsYu-Qing Chen, Ling-Ling Gao, Ling-Cong Kong, et al.
Thoracic Cancer|May 21, 2022
An integrated biomarker of PD-L1 expression and intraepithelial CD8+ T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastasesLin-Lin Li, De-Xiang Zhou, Ming Lu, et al.
Iscience|October 9, 2023
Spatial downregulation of CD74 signatures may drive invasive component development in part-solid lung adenocarcinomaJia-Tao Zhang, Juan Zhang, Song-Rong Wang, et al.
Journal of Thoracic Disease|October 23, 2023
Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancerShi-Ling Zhang, Chan-Yuan Zhang, Yu-Qing Chen, et al.
Clinical & Translational Immunology|June 5, 2024
Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma-like carcinomaYu-Min Zhong, Ji Chen, Jie Jiang, et al.
Thoracic Cancer|September 7, 2021
High SHP2 expression determines the efficacy of PD-1/PD-L1 inhibitors in advanced KRAS mutant non-small cell lung cancerHui-Bo Feng, Yu Chen, Zhi Xie, et al.
Pageof 2